Emirati company G20 has signed a strategic partnership agreement with the US' PharmXGen, so that it will be the exclusive agent to supply and distribute in the Middle East and North Africa the newest Rapid Antigen tests in the world. 

 

The agreement was signed by Dr Mubarak Hamad Marzouq Al Ameri, Chairman of the Board of Directors of the Emirati G20 company, and Bill Henwood, President of the American company PharmXGen, at the headquarters of the G20 Company in Abu Dhabi.

 

Dr Al Ameri said: “We are very pleased to cooperate with the American company PharmXGen, and we will be the exclusive agent for the company’s innovative intranasal Rapid Antigen tests, as they achieve speed in showing the test results in a period of time ranging from 3-10 minutes as a maximum, with a 100% efficiency. These tests have been approved by the US Food and Drug Administration, and they are used in the US, the UK, Germany and a number of countries in the world.

 

“The new screening tests are very important since they are the fastest in showing the results, whether negative or positive. In fact, the results appear in a maximum of 10 minutes, which allows a rapid gradual return to normal life. Indeed, the new tests will help organising events and activities and speeding up entry to government and private institutions and facilities, whether airports, hospitals, or the headquarters of institutions and departments.”

 

Dr Al Ameri explained that the speed of obtaining quick results will give the individuals more confidence and security, and help them to follow the precautionary measures established by the concerned authorities, which promotes a sense of confidence, and allows work and movement in a safe environment.

 

Henwood said: “We are pleased to cooperate with the Emirati company G20, which will be the exclusive agent for our products, especially those related to Rapid Antigen tests, as we have succeeded in creating and developing innovations that can show the results within 10 minutes, which is considered the fastest in the world, with a 100% efficiency.”

 

He added: "The tests manufactured by the company are approved by the US Food and Drug Administration and used in a number of countries, most notably the United States of America, the United Kingdom, Germany, China and other countries, and we are very happy that our tests will be used in the Middle East and North Africa, which will save time, and herald a rapid gradual return to normal life. These tests can be used by travelers, visitors to events and activities and exhibitions, and ordinary individuals who need quick and accurate results.” -- TradeArabia News Service